Healthcare Sector

Members of Parliament invested in the Healthcare Sector

160 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£156.57	262.10%	£253,466.70
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£156.57	239.41%	£237,587.26
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£11,650.00	-3.11%	£67,822.69
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£11,650.00	183.04%	£198,129.25
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£11,650.00	56.97%	£109,876.04
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£11,650.00	-1.05%	£69,262.78
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£11,650.00	336.90%	£305,831.61
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£11,758.00	-3.27%	£67,708.13
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£11,758.00	117.06%	£151,940.19
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£11,758.00	-1.39%	£69,025.49
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£11,758.00	14.94%	£80,455.52
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£11,758.00	46.88%	£102,818.24
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£11,758.00	300.20%	£280,142.95
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.17	-64.65%	£24,743.20
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£48.12	28.70%	£90,088.26
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£48.12	12.48%	£78,737.73
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£48.12	22.19%	£85,535.80
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£48.12	13.73%	£79,612.38
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£48.12	21.85%	£85,297.54
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£48.12	7.53%	£75,271.51
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£48.12	9.31%	£76,519.76
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£48.12	28.77%	£90,136.47
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£266.35	61.39%	£112,976.43
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£266.35	117.18%	£152,026.26
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£266.35	266.42%	£256,493.33
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£266.35	337.14%	£305,998.69
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£266.35	64.70%	£115,288.77
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£200.53	177.92%	£194,542.92
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£388.28	53.34%	£107,335.91
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£379.86	-22.49%	£54,259.07**
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£409.25	-23.91%	£53,264.97**
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£388.28	-25.07%	£52,450.02
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£400.94	-32.55%	£47,217.02**
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,280.58	90.42%	£133,296.55
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£603.18	44.25%	£100,977.18
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£603.18	31.34%	£91,940.16
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£603.18	3.35%	£72,343.57
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£603.18	30.27%	£91,185.64
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£475.66	-0.37%	£69,743.41**
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£158.20	-74.18%	£18,077.05
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£152.70	-52.28%	£33,403.12
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£44.01	21.07%	£84,751.03
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£44.01	-56.72%	£30,295.01
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£44.01	-64.15%	£25,097.35
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£44.01	-67.32%	£22,877.62
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£73.79	-56.10%	£30,727.54**
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£72.86	-55.25%	£31,324.16
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£137.48	55.56%	£108,888.89
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£137.48	108.15%	£145,705.30
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£137.48	154.40%	£178,078.88
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£246.00	8.13%	£75,692.31
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.70	27.73%	£89,414.34
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.70	3.89%	£72,724.05
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.70	25.76%	£88,033.62
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.70	6.17%	£74,320.13
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.70	4.11%	£72,877.03
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£103.36	309.08%	£286,358.08
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£103.36	-5.02%	£66,487.78
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£103.36	214.16%	£219,914.88
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.50	-84.68%	£10,721.34
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£27.65	41.47%	£99,029.95
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£27.65	-4.73%	£66,689.02
Aug '26	Lord Sassoon	Pfizer / NYQ:PFE	£27.97	£27.65	-1.14%	£69,199.14
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£27.62	22.19%	£85,529.59
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£27.62	31.65%	£92,152.71
Aug '26	Baroness Deech	Smith & Nephew / NYQ:SNN	£29.84	£27.62	-7.44%	£64,792.23
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£401.64	361.18%	£322,824.69
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£270.01	288.95%	£272,265.94
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£270.01	-1.81%	£68,729.82
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£52.80	10.46%	£77,322.18
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£52.80	-3.91%	£67,261.14
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£26.04	103.28%	£142,295.09
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£91.62	-9.08%	£63,643.95
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£95.29	19.95%	£83,966.51
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£49.26	-48.29%	£36,197.77
Aug '26	Baroness Deech	Bayer / GER:BAYN.DE	£48.00	£49.26	2.62%	£71,837.50
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£150.72	-44.94%	£38,540.27
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£255.00	58.57%	£111,000.56
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£360.46	29.73%	£90,812.30
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£360.46	2.76%	£71,929.64
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£360.46	-34.62%	£45,768.55
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29**
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£421.21	1,257.87%	£950,506.11
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.60	2.36%	£71,650.76
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,160.00	-19.34%	£56,460.04
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£506.53	1,590.69%	£1,183,481.35
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,123.00	53.56%	£107,489.09
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£1,123.00	17.57%	£82,297.76
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,498.00	-26.06%	£51,757.16
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.03	-97.62%	£1,665.51
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£970.30	74.20%	£121,940.75
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£11.33	709.29%	£566,500.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.57	33.85%	£93,697.91
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.52	-50.00%	£35,000.00
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£55.39	268.04%	£257,627.90
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.82	-93.13%	£4,806.67
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£18.89	77.87%	£124,510.35
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£11.00	-2.22%	£68,444.44
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£58.75	95.31%	£136,718.75
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£136.62	22.00%	£85,402.75
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£336.20	0.03%	£70,020.83
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£3.54	-72.06%	£19,561.27
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£145.85	-29.71%	£49,202.41
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£149.00	-45.46%	£38,177.16
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.22	-99.13%	£605.77
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£68.90	-38.48%	£43,062.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£71.00	37.86%	£96,504.85
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£1.11	-96.30%	£2,590.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.42	-13.42%	£60,607.60

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.